UnitedHealth price target raised to $408 from $286 at RBC Capital

RBC Capital analyst Ben Hendrix raised the firm’s price target on UnitedHealth (UNH) to $408 from $286 and keeps an Outperform rating on the shares after its Q3 earnings beat. The management voiced confidence in pricing actions and plan exits driving margin expansion across the enterprise next year, the analyst tells investors in a research note. With expectations of margin improvement accelerating in 2027, UnitedHealth should see EPS growth near the low-end of its long-term annual EPS growth target of 13%-16%, the firm added.